Peter Zhang, PhD

Effect of Adjunctive Brexpiprazole on Sexual Functioning in MDD According to Concomitant Antidepressant: Post Hoc Analysis of Four Short-Term Studies

Background: We aimed to determine the effects of adjunctive brexpiprazole on sexual functioning in adults with major depressive disorder (MDD), according to antidepressant treatment (ADT)...

Catherine Weiss , PhD;

Stine Rasmussen Meehan , PhD;

H. Lundbeck ;

Malaak Brubaker , PhD;

Peter Zhang , PhD;

Mary Hobart , PhD;

11/22/2019

Short- and Long-Term Metabolic Changes in Patients with MDD Treated with Adjunctive Brexpiprazole or Adjunctive Aripiprazole: An Indirect Comparison

Objective: We aimed to describe metabolic changes observed during short- and long-term studies of brexpiprazole and aripiprazole in patients with MDD.

Catherine Weiss , PhD;

Stine Rasmussen Meehan , PhD;

Peter Zhang , PhD;

Erin MacKenzie , PhD;

Francois Therrien , PharmD;

Ross Baker , PhD, MBA;

11/22/2019

Long-term Safety and Tolerability of Brexpiprazole as Adjunctive Therapy in Adults With Major Depressive Disorder

Objective: The Orion study (NCT01360866) evaluated the long-term safety, tolerability, and therapeutic effect of brexpiprazole (0.5–3 mg/day), as adjunct to antidepressant treatment, in a...

Aleksandar Skuban , MD;

Claudette Brewer , BA;

Peter Zhang , PhD;

Nanco Hefting , MSc;

Mary Hobart , PhD;

03/01/2019

Symptomatic and Functional Response to Brexpiprazole Treatment in Patients With Acute Schizophrenia by Age

Introduction: The efficacy and safety of brexpiprazole in the treatment of schizophrenia have been demonstrated in short- and long-term studies. This post-hoc analysis assessed the propor...

Catherine Weiss , PhD;

Stine Rasmussen Meehan , PhD;

H. Lundbeck ;

Peter Zhang , PhD;

Erin MacKenzie , PhD;

Francois Therrien , PharmD;

03/01/2019

Characteristics of Patients in Recovery Versus Patients With Recurrence in a Randomized Placebo-Controlled Study With Aripiprazole Once-Monthly as Maintenance Treatment for Bipolar I Disorder

Aims. To describe the background and clinical characteristics of patients who did versus those who did not have a recurrence of a mood episode during up to 52 weeks of maintenance treatme...

Peter Zhang , PhD;

Ross Baker , PhD, MBA;

Pedro Such , MD;

Jessica Madera , MD;

Mauricio Tohen , MD, DrPH, MBA;

03/01/2019

Assessment of Functional Recovery After Long-term Aripiprazole Once-Monthly Maintenance Treatment of Bipolar I Disorder

Background: Functional assessment is complex and often overlooked in patients with bipolar I disorder. The Functioning Assessment Short Test (FAST) assesses optimal functioning in these p...

Peter Zhang , PhD;

Ross Baker , PhD, MBA;

Thomas Brown , PhD;

Mauricio Tohen , MD, DrPH, MBA;

Pedro Such , MD;

Jessica Madera , MD;

Craig Surman , MD;

03/01/2019